- Home
- RVPH vs AMS Comparison
RVPH vs AMS Comparison
Compare RVPH & AMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- AMS
- Stock Information
- Founded
- RVPH 2006
- AMS 1980
- Country
- RVPH United States
- AMS United States
- Employees
- RVPH N/A
- AMS N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- AMS Medical Specialities
- Sector
- RVPH Health Care
- AMS Health Care
- Exchange
- RVPH Nasdaq
- AMS Nasdaq
- Market Cap
- RVPH 18.1M
- AMS 17.2M
- IPO Year
- RVPH N/A
- AMS N/A
- Fundamental
- Price
- RVPH $0.68
- AMS $2.44
- Analyst Decision
- RVPH Strong Buy
- AMS
- Analyst Count
- RVPH 6
- AMS 0
- Target Price
- RVPH $4.50
- AMS N/A
- AVG Volume (30 Days)
- RVPH 16.9M
- AMS 101.9K
- Earning Date
- RVPH 11-13-2025
- AMS 11-12-2025
- Dividend Yield
- RVPH N/A
- AMS N/A
- EPS Growth
- RVPH N/A
- AMS N/A
- EPS
- RVPH N/A
- AMS N/A
- Revenue
- RVPH N/A
- AMS $29,251,000.00
- Revenue This Year
- RVPH N/A
- AMS $5.06
- Revenue Next Year
- RVPH N/A
- AMS N/A
- P/E Ratio
- RVPH N/A
- AMS N/A
- Revenue Growth
- RVPH N/A
- AMS 26.61
- 52 Week Low
- RVPH $0.25
- AMS $2.27
- 52 Week High
- RVPH $4.28
- AMS $3.59
- Technical
- Relative Strength Index (RSI)
- RVPH 65.12
- AMS 48.23
- Support Level
- RVPH $0.29
- AMS $2.45
- Resistance Level
- RVPH $0.86
- AMS $2.58
- Average True Range (ATR)
- RVPH 0.07
- AMS 0.14
- MACD
- RVPH 0.05
- AMS 0.01
- Stochastic Oscillator
- RVPH 72.03
- AMS 15.28
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About AMS American Shared Hospital Services
American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy, and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities. The company, along with its subsidiaries, operates through the following operations: Gamma Knife, Advanced Radiation Therapy Equipment and Services, and Proton Beam Radiation Therapy Operations. It generates most of its revenue from the domestic market.